首页> 美国卫生研究院文献>other >Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials
【2h】

Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials

机译:神经反馈与哌醋甲酯对注意力不足/多动障碍治疗方案的影响用于系统评价和头对头试验的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:Attention-deficit/hyperactivity disorder (ADHD) is developmental disorder characterized by inattention and/or hyperactivity/impulsivity. Psychostimulants, including methylphenidate (MPH), are recommended as a first-line pharmacological intervention, whereas neurofeedback (NF) has been proposed as a nonpharmacological option. The comparative effects of MPH and NF need further exploration. We will conduct a systematic review and meta-analysis of head-to-head randomized controlled trials (RCTs) comparing the efficacy and/or tolerability of MPH and NF in children/adolescents and adults with ADHD.
机译:简介:注意缺陷多动障碍(ADHD)是一种以注意力不集中和/或活动过度/冲动为特征的发育障碍。建议使用精神兴奋剂,包括哌醋甲酯(MPH)作为一线药理干预措施,而神经反馈(NF)已被建议作为非药理选择。 MPH和NF的比较效果还有待进一步探索。我们将对头对头随机对照试验(RCT)进行系统的回顾和荟萃分析,比较MPH和NF在多动症儿童/青少年和成人中的疗效和/或耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号